Ownership

Vimal Mehta - CEO and President, Director, 10%+ Owner at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: CEO and President, Director, 10%+ Owner
Stock Symbol: BTAI on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Vimal Mehta - trading volume in the past year for BioXcel Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-265K	100%	$1.60	-$424K
Net	-265K	-100%		-$424K

Holdings reported by Vimal Mehta for BioXcel Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	7.69M	$2.79M	$0.36	Dec 14, 2024	By BioXcel LLC
Common Stock	59.6K	$21.6K	$0.36	Dec 16, 2024	Direct
Restricted Stock Units	31.5K	$11.4K	$0.36	Dec 15, 2024	Direct	Common Stock
Common Stock	2K	$725	$0.36	Dec 14, 2024	By spouse
Call Options (obligation to sell)	120			Jun 4, 2024	By BioXcel LLC	Common Stock

Transactions reported by Vimal Mehta for BioXcel Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.